Specialty
Among 2,001 high-thrombotic-risk STEMI patients treated with PCI, those who received post-PCI PACT had similar observed outcomes to those who did not, but the observational study could not establish equivalence.
Frontiers in pharmacology4 min read
People whose health vulnerability rose between two assessments had the highest observed cardiovascular disease risk in a 16,072-person UK Biobank analysis. Over a median 8.9 years, 3,033 first cardiovascular events were recorded.
Frontiers in public health5 min read
Children who underwent neonatal repair for aortic arch obstruction showed lower motor performance at later assessments, while cognitive scores were broadly comparable with normative expectations.
Frontiers in pediatrics5 min read
A survey of 105 pharmacists aged 45 or younger found strong interest in onco-cardiology but limited reported clinical experience, weaker hospital-community pharmacy collaboration and a strong demand for online education.
Circulation reports3 min read
In adults with fixed defects on sestamibi imaging, a later thallium scan reclassified nearly half of the affected segments and at least one segment in most patients, while leaving viability unresolved.
Frontiers in cardiovascular medicine4 min read
Researchers tested a new questionnaire designed to measure cardiovascular health beliefs, finding a six-part structure and consistent results across its subscales.
Patient related outcome measures4 min read
A laboratory co-culture of cardiomyocytes derived from human induced pluripotent stem cells and sympathetic nerve cells was reported to form a physical connection in a compartmentalized microfluidic device. The cells showed electrical and beating-rate responses to nicotine and propranolol, offering preliminary platform evidence for neuro-cardiac research.
Lab on a chip3 min read
In 1,198 non-shockable out-of-hospital cardiac arrests, 13.9% had any documented return of spontaneous circulation and 12.2% maintained it through EMS care. Witnessed arrests and PEA were associated with higher odds in adjusted models, while the study could not establish cause and effect.
International journal of emergency medicine4 min read
Among people with hypertension, esaxerenone was associated with fewer cardiovascular events than spironolactone, with the gap concentrated in heart failure and atrial fibrillation.
Journal of human hypertension4 min read